24小时热门版块排行榜

返回列表

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

右岸

金虫 (正式写手)

应助: 0 (幼儿园)
金币: 2872.5
散金: 50
帖子: 400
在线: 62.2小时
虫号: 946928
注册: 2010-01-22
性别: MM
专业: 有机化工

[求助] canertinib卡奈替尼这个抗肿瘤药物有没有上市？

canertinib卡奈替尼这个抗肿瘤药物有没有上市？如果有，什么时候？

回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐，对您同样有帮助:

1楼2011-12-25 00:42:02

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

右岸

金虫 (正式写手)

应助: 0 (幼儿园)
金币: 2872.5
散金: 50
帖子: 400
在线: 62.2小时
虫号: 946928
注册: 2010-01-22
性别: MM
专业: 有机化工

送鲜花一朵

引用回帖:

楼: Originally posted by hongju at 2011-12-25 16:13:43:
As no development has been reported for some time, this program is assumed to be discontinued.

Pfizer (formerly by Warner-Lambert), under license from the University of Auckland, was developing ...

谢谢

回复此楼

3楼2011-12-25 17:27:13

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

查看全部 5 个回答

hongju

捐助贵宾 (小有名气)

应助: 6 (幼儿园)
金币: 72
散金: 13
红花: 1
帖子: 106
在线: 68.3小时
虫号: 84623
注册: 2005-08-05
性别: MM
专业: 药物设计与药物信息

【答案】应助回帖

★ ★ ★
zhoudeli(金币+1): 多谢参与。 2011-12-25 17:47:35
mouse103: 应助指数+1 2012-05-20 05:30:39
右岸: 金币+2, ★有帮助 2012-06-01 22:12:38

As no development has been reported for some time, this program is assumed to be discontinued.

Pfizer (formerly by Warner-Lambert), under license from the University of Auckland, was developing canertinib (CI-1033, PD-0183805), a water soluble, orally-available analog of PD-169414, an EGFR tyrosine kinase inhibitor, as a potential treatment for cancer [427113]. By January 2000, phase I trials were underway [353284], [352930]. In September 2001, the drug was reported to be in phase II trials [427113], [429152]; these trials were ongoing in June 2004 [542422].